EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 120 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 4.58 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,740,283 | -16.1% | 110,354 | +3.4% | 0.00% | -100.0% |
| Q2 2023 | $2,073,762 | -32.4% | 106,675 | -1.3% | 0.00% | 0.0% |
| Q1 2023 | $3,067,619 | -35.6% | 108,129 | -33.6% | 0.00% | -50.0% |
| Q4 2022 | $4,762,473 | +25.9% | 162,931 | +13.8% | 0.00% | +100.0% |
| Q3 2022 | $3,782,000 | -30.5% | 143,124 | +16.8% | 0.00% | -50.0% |
| Q2 2022 | $5,443,000 | -0.5% | 122,494 | +10.8% | 0.00% | 0.0% |
| Q1 2022 | $5,472,000 | +10.6% | 110,564 | +13.8% | 0.00% | +100.0% |
| Q4 2021 | $4,947,000 | +9.3% | 97,142 | +19.7% | 0.00% | 0.0% |
| Q3 2021 | $4,527,000 | +31.1% | 81,143 | +0.6% | 0.00% | 0.0% |
| Q2 2021 | $3,452,000 | +7.4% | 80,656 | +4.7% | 0.00% | 0.0% |
| Q1 2021 | $3,215,000 | -8.2% | 77,003 | +2.4% | 0.00% | 0.0% |
| Q4 2020 | $3,502,000 | +7.8% | 75,194 | -1.7% | 0.00% | 0.0% |
| Q3 2020 | $3,250,000 | -0.7% | 76,493 | +12.2% | 0.00% | -50.0% |
| Q2 2020 | $3,272,000 | +18.3% | 68,194 | +13.4% | 0.00% | 0.0% |
| Q1 2020 | $2,767,000 | -58.1% | 60,147 | -45.2% | 0.00% | -50.0% |
| Q4 2019 | $6,597,000 | +2.5% | 109,787 | -3.4% | 0.00% | 0.0% |
| Q3 2019 | $6,433,000 | +3.2% | 113,708 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $6,234,000 | +26.2% | 111,946 | +14.4% | 0.00% | +33.3% |
| Q1 2019 | $4,940,000 | +56.3% | 97,835 | +24.7% | 0.00% | +50.0% |
| Q4 2018 | $3,161,000 | -45.5% | 78,432 | -6.3% | 0.00% | -50.0% |
| Q3 2018 | $5,801,000 | +59.4% | 83,669 | +73.9% | 0.00% | +33.3% |
| Q2 2018 | $3,640,000 | -20.7% | 48,100 | -44.8% | 0.00% | -25.0% |
| Q1 2018 | $4,591,000 | +28.1% | 87,125 | +29.9% | 0.00% | +33.3% |
| Q4 2017 | $3,585,000 | -1.0% | 67,094 | +10.5% | 0.00% | 0.0% |
| Q3 2017 | $3,622,000 | +23.9% | 60,716 | +63.9% | 0.00% | 0.0% |
| Q2 2017 | $2,924,000 | -3.0% | 37,053 | +2.0% | 0.00% | 0.0% |
| Q1 2017 | $3,013,000 | +10.2% | 36,316 | +5.4% | 0.00% | 0.0% |
| Q4 2016 | $2,733,000 | +12.4% | 34,441 | -0.8% | 0.00% | 0.0% |
| Q3 2016 | $2,431,000 | +104.5% | 34,718 | +13.3% | 0.00% | +200.0% |
| Q2 2016 | $1,189,000 | -2.6% | 30,642 | +1.7% | 0.00% | -50.0% |
| Q1 2016 | $1,221,000 | -49.1% | 30,132 | +11.4% | 0.00% | -33.3% |
| Q4 2015 | $2,399,000 | +23.4% | 27,055 | +3.1% | 0.00% | 0.0% |
| Q3 2015 | $1,944,000 | +93.4% | 26,251 | +111.3% | 0.00% | +200.0% |
| Q2 2015 | $1,005,000 | – | 12,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |